Vonoprazan vs Intravenous Proton Pump Inhibitor for Prevention of High-Risk Peptic Ulcer Rebleeding After Successful Endoscopic Hemostasis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Gastroenterology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Comparison of Vonoprazan versus Intravenous Proton Pump Inhibitor for Prevention of High-Risk Peptic Ulcers Rebleeding after Successful Endoscopic Hemostasis: A Multicenter Randomized Noninferiority Trial
Gastroenterology 2024 Apr 05;[EPub Ahead of Print], T Geeratragool, U Kaosombatwattana, A Boonchote, S Chatthammanat, N Preechakawin, J Srichot, A Sudcharoen, P Sirisunhirun, P Termsinsuk, M Rugivarodom, J Limsrivilai, M Maneerattanaporn, N Pausawasdi, S LeelakusolvongFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.